KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Total Debt (2018 - 2024)

BioNTech SE's Total Debt history spans 7 years, with the latest figure at $1.6 billion for Q4 2024.

  • For Q4 2024, Total Debt rose 226.02% year-over-year to $1.6 billion; the TTM value through Dec 2024 reached $1.6 billion, up 226.02%, while the annual FY2024 figure was $1.6 billion, 228.45% up from the prior year.
  • Total Debt for Q4 2024 was $1.6 billion at BioNTech SE, up from $488.5 million in the prior quarter.
  • Across five years, Total Debt topped out at $1.9 billion in Q4 2021 and bottomed at $48.4 million in Q4 2020.
  • The 5-year median for Total Debt is $807.2 million (2022), against an average of $965.3 million.
  • The largest annual shift saw Total Debt soared 3803.83% in 2021 before it plummeted 57.28% in 2022.
  • A 5-year view of Total Debt shows it stood at $48.4 million in 2020, then soared by 3803.83% to $1.9 billion in 2021, then tumbled by 57.28% to $807.2 million in 2022, then crashed by 39.49% to $488.5 million in 2023, then skyrocketed by 226.02% to $1.6 billion in 2024.
  • Per Business Quant, the three most recent readings for BNTX's Total Debt are $1.6 billion (Q4 2024), $488.5 million (Q4 2023), and $807.2 million (Q4 2022).